In her lab, Mary McCourt is busy developing a next-generation anti-viral therapy while training – and working alongside – the ...
FDA's reasoning appears to center on a belief that COVID-19 treatment immunobridging analyses for a monoclonal antibody (mAb) must meet a standard of superior antiviral activity rather than equivalent ...
RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is ...